These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38868307)

  • 1. Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City.
    Garcia EA; Foote MMK; McPherson TD; Lash MK; Bosompem AN; Bouscaren A; Chan J; DiLorenzo MA; Feihel D; Fowler RC; Gandhi V; Jenny-Avital ER; Kopping EJ; Mazo D; McLean J; Mgbako O; Sayegh MN; Shaw RN; Su M; Meissner JS; Wang JC; Wen W; Winters JC; Zeana CB; Zucker J; Wong M
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae294. PubMed ID: 38868307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System.
    Vo C; Zomorodi R; Silvera R; Bartram L; Lugo LA; Kojic E; Urbina A; Aberg J; Sigel K; Chasan R; Patel G
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad552. PubMed ID: 38023539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.
    Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Extended Antivirals With Antiretrovirals for Severe Mpox in Advanced Human Immunodeficiency Virus Infection: Case Series of 4 Patients.
    Duong MT; Tebas P; Ancha B; Baron J; Chary P; Isaacs SN; Szep Z
    Open Forum Infect Dis; 2024 Mar; 11(3):ofae110. PubMed ID: 38486814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mpox in people with advanced HIV infection: a global case series.
    Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
    Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging pharmacological strategies for treating and preventing mpox.
    Grosenbach DW; Russo AT; Blum ED; Hruby DE
    Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
    Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
    Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection.
    Fortier JC; Marsalisi C; Cordova E; Guo HJ; Verdecia J
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae138. PubMed ID: 38651138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS.
    Thet AK; Kelly PJ; Kasule SN; Shah AK; Chawala A; Latif A; Chilimuri SS; Zeana CB
    Clin Infect Dis; 2023 May; 76(9):1671-1673. PubMed ID: 36571287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutics for treating mpox in humans.
    Fox T; Gould S; Princy N; Rowland T; Lutje V; Kuehn R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD015769. PubMed ID: 36916727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prolonged Case of Severe Mpox as an Opportunistic Infection in Advanced AIDS.
    Malka MS; Parkinson M; Zucker J; McLean JR; Pereira MR; Yin MT; Gunaratne SH
    Cureus; 2024 May; 16(5):e59947. PubMed ID: 38854169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
    Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
    J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tecovirimat Treatment of People With HIV During the 2022 Mpox Outbreak : A Retrospective Cohort Study.
    McLean J; Stoeckle K; Huang S; Berardi J; Gray B; Glesby MJ; Zucker J
    Ann Intern Med; 2023 May; 176(5):642-648. PubMed ID: 37126820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.
    Harrison I; DeSear K; Santevecchi BA; Venugopalan V; Cherabuddi K; Iovine N; Radhakrishnan N
    Int J STD AIDS; 2024 Jul; 35(8):651-653. PubMed ID: 38502040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
    Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
    De Clercq E; Jiang Y; Li G
    Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic agents for the treatment of human mpox.
    Braddick M; Singh KP
    Curr Opin Infect Dis; 2024 Dec; 37(6):518-525. PubMed ID: 39382085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Mpox Disease in People With Advanced HIV: Characterization of Mpox Skin Lesions.
    O'Shea J; Zucker J; Stampfer S; Cash-Goldwasser S; Minhaj FS; Dretler A; Cheeley J; Chaudhuri S; Gallitano SM; Gunaratne S; Parkinson M; Epling B; Morcock DR; Sereti I; Deleage C
    J Infect Dis; 2024 Mar; 229(Supplement_2):S243-S248. PubMed ID: 38019806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review.
    Bruno G; Buccoliero GB
    Life (Basel); 2023 Sep; 13(10):. PubMed ID: 37895350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe ocular Mpox in person living with advanced HIV treated with extended course of tecovirimat.
    Brown L; Sargent P; Islam M; Downie C; Hassan A; O'Hara G; Douthwaite S; Kulasegaram R; Robbie S; Aarons E; Milligan ID
    HIV Med; 2024 Sep; 25(9):1086-1090. PubMed ID: 38725328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.